Sara Mangsbo, PhDSenior Associate Lecturer at Uppsala University
Sara Mangsbo (PhD) is Associate senior lecturer in antibody drugs and Associate professor in Experimental clinical immunology at Uppsala University. Dr Mangsbo is a leader in the field of cancer immunotherapy and specifically in antibody-based drug delivery and synthetic long peptides and was recently awarded the SITC team award within the SLP stream. She is a serial entrepreneur and has founded Immuneed AB, a service provider of immunotoxicity measurements in human whole blood. She is the Chief Development Officer of Ultimovacs and the co-founder of STRIKE pharma AB. She drives a translational research project with the ambition and track-record of taking research projects into clinical trial testing.